The latest closing stock price for Verve Therapeutics as of May 22, 2025 is 4.38.
An investor who bought $1,000 worth of Verve Therapeutics stock at the IPO in 2021 would have $-863 today, roughly -1 times their original investment - a -39.14% compound annual growth rate over 4 years.
The all-time high Verve Therapeutics stock closing price was 73.99 on September 10, 2021.
The Verve Therapeutics 52-week high stock price is 9.30, which is 112.3% above the current share price.
The Verve Therapeutics 52-week low stock price is 2.86, which is 34.7% below the current share price.
The average Verve Therapeutics stock price for the last 52 weeks is 5.73.
An investor who bought $1,000 worth of Verve Therapeutics stock at the IPO in 2021 would have $-863 today, roughly -1 times their original investment - a -39.14% compound annual growth rate over 4 years.
The all-time high Verve Therapeutics stock closing price was 73.99 on September 10, 2021.
The Verve Therapeutics 52-week high stock price is 9.30, which is 112.3% above the current share price.
The Verve Therapeutics 52-week low stock price is 2.86, which is 34.7% below the current share price.
The average Verve Therapeutics stock price for the last 52 weeks is 5.73.